期刊
ANTIOXIDANTS
卷 12, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/antiox12020280
关键词
neurotoxicity; neuroinflammation; reactive oxygen derivatives; depression; Parkinson; Alzheimer; flavonoids; hesperidin; quercetin
Neurological and neurodegenerative diseases, especially those associated with aging, are increasing, and natural substances such as flavonoids have been studied for their neuroprotective effects. Studies on animal models have shown that hesperidin and quercetin, two commonly used flavonoids, have the potential to prevent or mitigate the effects of depression, neurotoxicity, Alzheimer's disease, and Parkinson's disease. These substances have been found to modulate various mechanisms and targets, including oxidative stress, inflammation, and neuroinflammatory processes. While clinical trials on humans are limited, preclinical studies suggest that hesperidin, quercetin, and other flavonoids could be promising dietary molecules for the prevention and management of neurodegenerative diseases.
Neurological and neurodegenerative diseases, particularly those related to aging, are on the rise, but drug therapies are rarely curative. Functional disorders and the organic degeneration of nervous tissue often have complex causes, in which phenomena of oxidative stress, inflammation and cytotoxicity are intertwined. For these reasons, the search for natural substances that can slow down or counteract these pathologies has increased rapidly over the last two decades. In this paper, studies on the neuroprotective effects of flavonoids (especially the two most widely used, hesperidin and quercetin) on animal models of depression, neurotoxicity, Alzheimer's disease (AD) and Parkinson's disease are reviewed. The literature on these topics amounts to a few hundred publications on in vitro and in vivo models (notably in rodents) and provides us with a very detailed picture of the action mechanisms and targets of these substances. These include the decrease in enzymes that produce reactive oxygen and ferroptosis, the inhibition of mono-amine oxidases, the stimulation of the Nrf2/ARE system, the induction of brain-derived neurotrophic factor production and, in the case of AD, the prevention of amyloid-beta aggregation. The inhibition of neuroinflammatory processes has been documented as a decrease in cytokine formation (mainly TNF-alpha and IL-1beta) by microglia and astrocytes, by modulating a number of regulatory proteins such as Nf-kB and NLRP3/inflammasome. Although clinical trials on humans are still scarce, preclinical studies allow us to consider hesperidin, quercetin, and other flavonoids as very interesting and safe dietary molecules to be further investigated as complementary treatments in order to prevent neurodegenerative diseases or to moderate their deleterious effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据